Works by STELITANO, CATERINA

Results: 59
    1

    Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub‐Study of the FOLL12 Trial.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 7, p. 1196, doi. 10.1002/ajh.27711
    By:
    • Durmo, Rexhep;
    • Chauvie, Stephane;
    • Minoia, Carla;
    • Bergesio, Fabrizio;
    • Fallanca, Federico;
    • Peano, Simona;
    • Marcheselli, Luigi;
    • Anastasia, Antonella;
    • Boccomini, Carola;
    • Corradini, Paolo;
    • Olivieri, Jacopo;
    • Arcaini, Luca;
    • Cavallo, Federica;
    • Ibatici, Adalberto;
    • Nassi, Luca;
    • Tarantino, Vittoria;
    • Pinto, Antonello;
    • Stelitano, Caterina;
    • Pulsoni, Alessandro;
    • Ricci, Francesca
    Publication type:
    Article
    2
    3

    Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.

    Published in:
    2020
    By:
    • Ferreri, Andrés J. M.;
    • Sassone, Marianna;
    • Angelillo, Piera;
    • Zaja, Francesco;
    • Re, Alessandro;
    • Di Rocco, Alice;
    • Spina, Michele;
    • Fabbri, Alberto;
    • Stelitano, Caterina;
    • Frezzato, Maurizio;
    • Volpetti, Stefano;
    • Zambello, Renato;
    • Rusconi, Chiara;
    • De Lorenzo, Daniela;
    • Scarano, Eloise;
    • Arcari, Annalisa;
    • Bertoldero, Giovanni;
    • Nonis, Alessandro;
    • Calimeri, Teresa;
    • Perrone, Salvatore
    Publication type:
    journal article
    4

    Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.

    Published in:
    Hematological Oncology, 2013, v. 31, n. 3, p. 143, doi. 10.1002/hon.2037
    By:
    • Mappa, Silvia;
    • Marturano, Emerenziana;
    • Licata, Giada;
    • Frezzato, Maurizio;
    • Frungillo, Niccolò;
    • Ilariucci, Fiorella;
    • Stelitano, Caterina;
    • Ferrari, Antonella;
    • Sorarù, Mariella;
    • Vianello, Fabrizio;
    • Baldini, Luca;
    • Proserpio, Ilaria;
    • Foppoli, Marco;
    • Assanelli, Andrea;
    • Reni, Michele;
    • Caligaris‐Cappio, Federico;
    • Ferreri, Andrés J. M.
    Publication type:
    Article
    5
    6

    Bleomycin, Epidoxorubicin, Cyclophosphamide, Vincristine and Prednisone (BACOP) in Patients with Follicular Non-Hodgkin's Lymphoma: Results of a Prospective, Multicenter Study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).

    Published in:
    Leukemia & Lymphoma, 2002, v. 43, n. 9, p. 1795, doi. 10.1080/1042819021000006457
    By:
    • Lombardo, Marco;
    • Morabito, Fortunato;
    • Merli, Francesco;
    • Molica, Stefano;
    • Cavanna, Luigi;
    • Sacchi, Stefano;
    • Broglia, Chiara;
    • Angrilli, Francesco;
    • Ilariucci, Fiorella;
    • Stelitano, Caterina;
    • Luisi, Dimitri;
    • Berte, Raffaella;
    • Luminari, Stefano;
    • Federico, Massimo;
    • Brugiatelli, Maura
    Publication type:
    Article
    7
    8
    9

    A brief rituximab, bendamustine, mitoxantrone (R‐BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 2, p. 280, doi. 10.1111/bjh.17283
    By:
    • Boccomini, Carola;
    • Ladetto, Marco;
    • Rigacci, Luigi;
    • Puccini, Benedetta;
    • Rattotti, Sara;
    • Volpetti, Stefano;
    • Ferrero, Simone;
    • Chiarenza, Annalisa;
    • Freilone, Roberto;
    • Novo, Mattia;
    • Corradini, Paolo;
    • Nassi, Luca;
    • Rusconi, Chiara;
    • Stelitano, Caterina;
    • Bolis, Silvia;
    • Marina Liberati, Anna;
    • Tucci, Alessandra;
    • Baldini, Luca;
    • Balzarotti, Monica;
    • Evangelista, Andrea
    Publication type:
    Article
    10

    Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1011, doi. 10.1111/bjh.16714
    By:
    • Massaro, Fulvio;
    • Stepanishyna, Yana;
    • Manni, Martina;
    • Luminari, Stefano;
    • Galimberti, Sara;
    • Marcheselli, Luigi;
    • Visco, Carlo;
    • Tecchio, Cristina;
    • Stelitano, Caterina;
    • Angrilli, Francesco;
    • Petrini, Mario;
    • Merli, Francesco;
    • Federico, Massimo
    Publication type:
    Article
    11

    TCL-386: Patterns of Care for Elderly Patients with Peripheral T-Cell Lymphoma: A Report from the International T-Cell Project 1.0.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S415, doi. 10.1016/S2152-2650(21)01932-7
    By:
    • Skrypets, Tetiana;
    • Civallero, Monica;
    • Manni, Martina;
    • Vose, Julie Marie;
    • Dlouhy, Ivan;
    • Pileri, Stefano;
    • Maria, Elena Cabrera M.E.;
    • Hitz, Felicitas;
    • Inghirami, Giorgio;
    • Bobillo, Sabela;
    • Marino, Dario;
    • Advani, Ranjana;
    • Stelitano, Caterina;
    • Federico, Massimo
    Publication type:
    Article
    12

    Poster: TCL-386: Patterns of Care for Elderly Patients with Peripheral T-Cell Lymphoma: A Report from the International T-Cell Project 1.0.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S248, doi. 10.1016/S2152-2650(21)01559-7
    By:
    • Skrypets, Tetiana;
    • Civallero, Monica;
    • Manni, Martina;
    • Vose, Julie Marie;
    • Dlouhy, Ivan;
    • Pileri, Stefano;
    • E, Maria Elena Cabrera M.;
    • Hitz, Felicitas;
    • Inghirami, Giorgio;
    • Bobillo, Sabela;
    • Marino, Dario;
    • Advani, Ranjana;
    • Stelitano, Caterina;
    • Federico, Massimo
    Publication type:
    Article
    13

    Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma.

    Published in:
    2011
    By:
    • Gobbi, Paolo G.;
    • Valentino, Francesco;
    • Bassi, Emilio;
    • Coriani, Chiara;
    • Merli, Francesco;
    • Bonfante, Valeria;
    • Marchianò, Alfonso;
    • Gallamini, Andrea;
    • Bolis, Silvia;
    • Stelitano, Caterina;
    • Levis, Alesssandro;
    • Federico, Massimo;
    • Angrilli, Francesco;
    • Di Giulio, Giuseppe;
    • Corazza, Gino R.
    Publication type:
    Journal Article
    14

    Chemoresistance As a Function of the Pretherapy Tumor Burden and the Chemotherapy Regimen Administered: Differences Observed With 2 Current Chemotherapy Regimens for Advanced Hodgkin Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 5, p. 396, doi. 10.1016/j.clml.2011.04.008
    By:
    • Gobbi, Paolo G.;
    • Valentino, Francesco;
    • Bassi, Emilio;
    • Coriani, Chiara;
    • Merli, Francesco;
    • Bonfante, Valeria;
    • Marchianò, Alfonso;
    • Gallamini, Andrea;
    • Bolis, Silvia;
    • Stelitano, Caterina;
    • Levis, Alessandro;
    • Federico, Massimo;
    • Angrilli, Francesco;
    • Di Giulio, Giuseppe;
    • Corazza, Gino R.
    Publication type:
    Article
    15

    Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T‐cell lymphomas, unspecified, and 496 diffuse large B‐cell lymphomas: Experience of the Intergruppo Italiano LinfomiInstitutions participating in the Intergruppo Italiano Linfomi study of peripheral T‐cell lymphoma include the following (principal investigators are listed in parentheses): Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy (A. Gallamini, D. Mattei, and R. Calvi); Struttura Complessa di Ematologia, Azienda Ospedaliera San Giovanni Battista, Turin, Italy (E. Gallo and U. Vitolo); Cattedra di Ematologia, Università degli Studi di Torino, Turin, Italy (M. Boccadoro, C. Tarella, and M. Ladetto); Divisione di Onco‐Ematologia, Istituto di Ricovero a Carattere Scientifico Candiolo, Turin, Italy (M. Aglietta and D. Rota Scalabrini); Struttura Complessa di Medicina, Ospedale di Biella, Biella, Italy (S. Fontana and A. Tonso); Struttura Complessa di M

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 7, p. 1601, doi. 10.1002/cncr.20531
    By:
    • Fortunato Morabito;
    • Andrea Gallamini;
    • Caterina Stelitano;
    • Vincenzo Callea;
    • Cesare Guglielmi;
    • Santo Neri;
    • Antonio Lazzaro;
    • Lorella Orsucci;
    • Fiorella Ilariucci;
    • Stefano Sacchi;
    • Umberto Vitolo;
    • Massimo Federico
    Publication type:
    Article
    16
    17
    18

    Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial.

    Published in:
    Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 138
    By:
    • Iannitto, Emilio;
    • Minardi, Viviana;
    • Gobbi, Paolo G.;
    • Calvaruso, Giuseppina;
    • Tripodo, Claudio;
    • Marcheselli, Luigi;
    • Luminari, Stefano;
    • Merli, Francesco;
    • Baldini, Luca;
    • Stelitano, Caterina;
    • Callea, Vincenzo;
    • Petrini, Mario;
    • Angrilli, Francesco;
    • Quarta, Giovanni;
    • Vallisa, Daniele;
    • Molica, Stefano;
    • Liardo, Eliana;
    • Polimeno, Giuseppe;
    • Brugiatelli, Maura;
    • Federico, Massimo
    Publication type:
    Article
    19

    Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review.

    Published in:
    Cancers, 2024, v. 16, n. 8, p. 1475, doi. 10.3390/cancers16081475
    By:
    • Criscuolo, Marianna;
    • Tosti, Maria Elena;
    • Broccoli, Alessandro;
    • Varettoni, Marzia;
    • Maraglino, Alessio Maria Edoardo;
    • Anastasia, Antonella;
    • Cantonetti, Maria;
    • Trentin, Livio;
    • Kovalchuk, Sofia;
    • Orsucci, Lorella;
    • Deodato, Marina;
    • Spolzino, Angelica;
    • Volpetti, Stefano;
    • Annibali, Ombretta;
    • Storti, Sergio;
    • Stelitano, Caterina;
    • Marchesi, Francesco;
    • Morè, Sonia;
    • Fianchi, Luana;
    • Falini, Brunangelo
    Publication type:
    Article
    20

    Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study.

    Published in:
    Cancers, 2022, v. 14, n. 1, p. 207, doi. 10.3390/cancers14010207
    By:
    • Mauro, Francesca Romana;
    • Paoloni, Francesca;
    • Molica, Stefano;
    • Reda, Gianluigi;
    • Trentin, Livio;
    • Sportoletti, Paolo;
    • Marchetti, Monia;
    • Pietrasanta, Daniela;
    • Marasca, Roberto;
    • Gaidano, Gianluca;
    • Coscia, Marta;
    • Stelitano, Caterina;
    • Mannina, Donato;
    • Di Renzo, Nicola;
    • Ilariucci, Fiorella;
    • Liberati, Anna Marina;
    • Orsucci, Lorella;
    • Re, Francesca;
    • Tani, Monica;
    • Musuraca, Gerardo
    Publication type:
    Article
    21

    Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

    Published in:
    Cancers, 2021, v. 13, n. 13, p. 3240, doi. 10.3390/cancers13133240
    By:
    • Mauro, Francesca Romana;
    • Giannarelli, Diana;
    • Visentin, Andrea;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Frustaci, Anna Maria;
    • Chiarenza, Annalisa;
    • Ciolli, Stefania;
    • Vitale, Candida;
    • Laurenti, Luca;
    • De Paoli, Lorenzo;
    • Murru, Roberta;
    • Gentile, Massimo;
    • Rigolin, Gian Matteo;
    • Levato, Luciano;
    • Giordano, Annamaria;
    • Del Poeta, Giovanni;
    • Stelitano, Caterina;
    • Ielo, Claudia;
    • Noto, Alessandro
    Publication type:
    Article
    22
    23

    The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study.

    Published in:
    European Journal of Haematology, 2006, v. 76, n. 3, p. 217, doi. 10.1111/j.1600-0609.2005.00609.x
    By:
    • Federico, Massimo;
    • Luminari, Stefano;
    • Gobbi, Paolo G.;
    • Sacchi, Stefano;
    • Renzo, Nicola;
    • Lombardo, Marco;
    • Merli, Francesco;
    • Baldini, Luca;
    • Stelitano, Caterina;
    • Partesotti, Giovanni;
    • Polimeno, Giuseppe;
    • Montanini, Antonella;
    • Mammi, Caterina;
    • Brugiatelli, Maura
    Publication type:
    Article
    24
    25

    Identifying and managing CAR T-cell–mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.

    Published in:
    Expert Opinion on Biological Therapy, 2022, v. 22, n. 3, p. 407, doi. 10.1080/14712598.2021.1974394
    By:
    • Martino, Massimo;
    • Macheda, Sebastiano;
    • Aguglia, Umberto;
    • Arcudi, Luciano;
    • Pucci, Giulia;
    • Martino, Bruno;
    • Altomonte, Maria;
    • Rossetti, Antonio Maria;
    • Cusumano, Giuseppa;
    • Russo, Letteria;
    • Imbalzano, Lucrezia;
    • Stelitano, Caterina;
    • Alati, Caterina;
    • Germano', Jessyca;
    • Labate, Demetrio;
    • Amalfi, Vincenzo;
    • Florenzano, Maria Teresa;
    • Morabito, Antonella;
    • Borzumati, Vittoria;
    • Dattola, Vincenzo
    Publication type:
    Article
    26

    Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study.

    Published in:
    2020
    By:
    • Rigacci, Luigi;
    • Puccini, Benedetta;
    • Broccoli, Alessandro;
    • Dona, Manjola;
    • Gotti, Manuel;
    • Evangelista, Andrea;
    • Santoro, Armando;
    • Bonfichi, Maurizio;
    • Re, Alessandro;
    • Spina, Michele;
    • Botto, Barbara;
    • Pulsoni, Alessandro;
    • Pagani, Chiara;
    • Stelitano, Caterina;
    • Salvi, Flavia;
    • Nassi, Luca;
    • Mannelli, Lara;
    • Kovalchuk, Sofia;
    • Gioia, Daniela;
    • Zinzani, Pier Luigi
    Publication type:
    journal article
    27

    Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trialof the Gruppo Italiano per lo Studio dei Linfomi (GISL).

    Published in:
    Annals of Hematology, 2011, v. 90, n. 3, p. 323, doi. 10.1007/s00277-010-1067-1
    By:
    • Ferrario, Andrea;
    • Merli, Francesco;
    • Luminari, Stefano;
    • Stelitano, Caterina;
    • Mannina, Donato;
    • Russo, Mario;
    • Mazza, Patrizio;
    • Marcheselli, Luigi;
    • Goldaniga, Maria Cecilia;
    • Federico, Massimo;
    • Baldini, Luca
    Publication type:
    Article
    28
    29

    Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67906-w
    By:
    • Clerico, Michele;
    • Ferrero, Simone;
    • Alessandria, Beatrice;
    • Zaccaria, Gian Maria;
    • Genuardi, Elisa;
    • Ragaini, Simone;
    • Tavarozzi, Rita;
    • Cavallo, Federica;
    • Hohaus, Stefan;
    • Musuraca, Gerardo;
    • Carella, Angelo Michele;
    • Stelitano, Caterina;
    • Tani, Monica;
    • Gaidano, Gianluca;
    • Olivieri, Jacopo;
    • Usai, Sara Veronica;
    • Galimberti, Sara;
    • Re, Francesca;
    • Mian, Michael;
    • Castellino, Claudia
    Publication type:
    Article
    30
    31

    Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 5, p. 755, doi. 10.1111/bjh.15641
    By:
    • Iannitto, Emilio;
    • Bellei, Monica;
    • Amorim, Sandy;
    • Ferreri, Andrés J. M.;
    • Marcheselli, Luigi;
    • Cesaretti, Marina;
    • Haioun, Corinne;
    • Mancuso, Salvatrice;
    • Bouabdallah, Krimo;
    • Gressin, Remy;
    • Tripodo, Claudio;
    • Traverse‐Glehen, Alexandra;
    • Baseggio, Lucile;
    • Zupo, Simonetta;
    • Stelitano, Caterina;
    • Castagnari, Barbara;
    • Patti, Caterina;
    • Alvarez, Isabel;
    • Liberati, Anna Marina;
    • Merli, Michele
    Publication type:
    Article
    32

    Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18- FDG PET/ CT quantitative parameters in the International Extranodal Lymphoma Study Group ( IELSG) 26 study.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 4, p. 588, doi. 10.1111/bjh.14728
    By:
    • Ceriani, Luca;
    • Martelli, Maurizio;
    • Conconi, Annarita;
    • Zinzani, Pier L.;
    • Ferreri, Andrés J. M.;
    • Botto, Barbara;
    • Stelitano, Caterina;
    • Gotti, Manuel;
    • Cabras, Maria G.;
    • Rigacci, Luigi;
    • Giovanella, Luca;
    • Zucca, Emanuele;
    • Johnson, Peter W. M.
    Publication type:
    Article
    33

    Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi ( FIL).

    Published in:
    British Journal of Haematology, 2016, v. 172, n. 6, p. 879, doi. 10.1111/bjh.13904
    By:
    • Zallio, Francesco;
    • Tamiazzo, Stefania;
    • Monagheddu, Chiara;
    • Merli, Francesco;
    • Ilariucci, Fiorella;
    • Stelitano, Caterina;
    • Liberati, Anna Marina;
    • Mannina, Donato;
    • Vitolo, Umberto;
    • Angelucci, Emanuele;
    • Rota Scalabrini, Delia;
    • Vallisa, Daniele;
    • Bellei, Monica;
    • Bari, Alessia;
    • Ciccone, Giovannino;
    • Salvi, Flavia;
    • Levis, Alessandro
    Publication type:
    Article
    34

    Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2013, v. 160, n. 2, p. 207, doi. 10.1111/bjh.12120
    By:
    • Corazzelli, Gaetano;
    • Angrilli, Francesco;
    • D'Arco, Alfonso;
    • Ferrara, Felicetto;
    • Musto, Pellegrino;
    • Guarini, Attilio;
    • Cox, Maria Christina;
    • Stelitano, Caterina;
    • Storti, Sergio;
    • Iannitto, Emilio;
    • Falorio, Simona;
    • Califano, Catello;
    • Amore, Alfonso;
    • Arcamone, Manuela;
    • Filippi, Rosaria;
    • Pinto, Antonio
    Publication type:
    Article
    35

    Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.

    Published in:
    British Journal of Haematology, 2012, v. 156, n. 3, p. 346, doi. 10.1111/j.1365-2141.2011.08958.x
    By:
    • Merli, Francesco;
    • Luminari, Stefano;
    • Ilariucci, Fiorella;
    • Petrini, Mario;
    • Visco, Carlo;
    • Ambrosetti, Achille;
    • Stelitano, Caterina;
    • Caracciolo, Francesco;
    • Di Renzo, Nicola;
    • Angrilli, Francesco;
    • Carella, Angelo M.;
    • Capodanno, Isabella;
    • Barbolini, Elisa;
    • Galimberti, Sara;
    • Federico, Massimo
    Publication type:
    Article
    36

    Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 551, doi. 10.1111/j.1365-2141.2010.08485.x
    By:
    • Gallamini, Andrea;
    • Patti, Caterina;
    • Viviani, Simonetta;
    • Rossi, Andrea;
    • Fiore, Francesca;
    • Di Raimondo, Francesco;
    • Cantonetti, Maria;
    • Stelitano, Caterina;
    • Feldman, Tatyana;
    • Gavarotti, Paolo;
    • Sorasio, Roberto;
    • Mulè, Antonino;
    • Leone, Monica;
    • Rambaldi, Alessandro;
    • Biggi, Alberto;
    • Barrington, Sally;
    • Fallanca, Federico;
    • Ficola, Umberto;
    • Chauvie, Stéphane;
    • Gianni, Alessandro Massimo
    Publication type:
    Article
    37

    Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.

    Published in:
    Oncogene, 2005, v. 24, n. 15, p. 2461, doi. 10.1038/sj.onc.1208447
    By:
    • Mattioli, Michela;
    • Agnelli, Luca;
    • Fabris, Sonia;
    • Baldini, Luca;
    • Morabito, Fortunato;
    • Bicciato, Silvio;
    • Verdelli, Donata;
    • Intini, Daniela;
    • Nobili, Lucia;
    • Cro, Lilla;
    • Pruneri, Giancarlo;
    • Callea, Vincenzo;
    • Stelitano, Caterina;
    • Maiolo, Anna Teresa;
    • Lombardi, Luigia;
    • Neri, Antonino
    Publication type:
    Article
    38

    Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study.

    Published in:
    Advances in Hematology, 2022, p. 1, doi. 10.1155/2022/5581772
    By:
    • Petrini, Mario;
    • Gaidano, Gianluca;
    • Mengarelli, Andrea;
    • Consoli, Ugo;
    • Santoro, Armando;
    • Liberati, Anna Maria;
    • Ladetto, Marco;
    • Fraticelli, Vincenzo;
    • Guarini, Attilio;
    • Mannina, Donato;
    • Ferrando, Paola;
    • Corradini, Paolo;
    • Musto, Pellegrino;
    • Stelitano, Caterina;
    • Marino, Dario;
    • Camera, Andrea;
    • Murineddu, Marco;
    • Battistini, Roberta;
    • Caparrotti, Giuseppe;
    • Turrini, Mauro
    Publication type:
    Article
    39

    A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.

    Published in:
    Acta Haematologica, 2017, v. 137, n. 1, p. 7, doi. 10.1159/000449052
    By:
    • Bari, alessia;
    • Marcheselli, Raffaella;
    • Marcheselli, Luigi;
    • alvarez, Isabel;
    • Pozzi, Samantha;
    • Ferri, Paola;
    • Lazzaro, antonio;
    • Fragasso, alberto;
    • Neri, Santo;
    • Baldini, Luca;
    • Carella, angelo Michele;
    • angrilli, Francesco;
    • Guariglia, Roberto;
    • Buda, Gabriele;
    • Stelitano, Caterina;
    • Sacchi, Stefano
    Publication type:
    Article
    40

    Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. E176, doi. 10.1002/ajh.26502
    By:
    • Molica, Stefano;
    • Giannarelli, Diana;
    • Visentin, Andrea;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Frustaci, Anna Maria;
    • Chiarenza, Annalisa;
    • Ciolli, Stefania;
    • Vitale, Candida;
    • Laurenti, Luca;
    • De Paoli, Lorenzo;
    • Murru, Roberta;
    • Gentile, Massimo;
    • Moia, Riccardo;
    • Rigolin, Gian Matteo;
    • Levato, Luciano;
    • Giordano, Annamaria;
    • Del Poeta, Giovanni;
    • Stelitano, Caterina;
    • Deodato, Marina
    Publication type:
    Article
    41
    42
    43
    44

    The prognostic value of positron emission tomography performed after two courses ( INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 6, p. 499, doi. 10.1002/ajh.23994
    By:
    • Rigacci, Luigi;
    • Puccini, Benedetta;
    • Zinzani, Pier Luigi;
    • Biggi, Alberto;
    • Castagnoli, Antonio;
    • Merli, Francesco;
    • Balzarotti, Monica;
    • Stelitano, Caterina;
    • Spina, Michele;
    • Vitolo, Umberto;
    • Stefoni, Vittorio;
    • Levis, Alessandro;
    • Gotti, Manuel;
    • Rosaria, Sancetta;
    • Maria, Stefani Piero;
    • Bosi, Alberto;
    • Gallamini, Andrea
    Publication type:
    Article
    45
    46
    47

    Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 12, p. 2890, doi. 10.1080/10428194.2019.1608529
    By:
    • Salvi, Flavia;
    • Luminari, Stefano;
    • Tucci, Alessandra;
    • Massidda, Stefania;
    • Liberati, Anna Marina;
    • Stelitano, Caterina;
    • Zanni, Manuela;
    • Re, Alessandro;
    • Centurioni, Riccardo;
    • Freilone, Roberto;
    • Musuraca, Gerardo;
    • Nassi, Luca;
    • Patti, Caterina;
    • Arcari, Annalisa;
    • Tani, Monica;
    • Pulsoni, Alessandro;
    • Pavone, Vincenzo;
    • Volpetti, Stefano;
    • Peli, Annalisa;
    • Evangelista, Andrea
    Publication type:
    Article
    48

    B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL).

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 10, p. 2375, doi. 10.3109/10428194.2016.1140161
    By:
    • Balzarotti, Monica;
    • Brusamolino, Ercole;
    • Angelucci, Emanuele;
    • Carella, Angelo Michele;
    • Vitolo, Umberto;
    • Russo, Eleonora;
    • Congiu, Angelagiovanna;
    • Gotti, Manuel;
    • Massidda, Stefania;
    • Botto, Barbara;
    • Annechini, Giorgia;
    • Spina, Michele;
    • Re, Alessandro;
    • Zilioli, Vittorio Ruggero;
    • Merli, Francesco;
    • Salvi, Flavia;
    • Stelitano, Caterina;
    • Bonfichi, Maurizio;
    • Rodari, Marcello;
    • Murru, Roberta
    Publication type:
    Article
    49
    50

    Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 12, p. 3281, doi. 10.3109/10428194.2015.1029925
    By:
    • Iannitto, Emilio;
    • Luminari, Stefano;
    • Tripodo, Claudio;
    • Mancuso, Salvatrice;
    • Cesaretti, Marina;
    • Marcheselli, Luigi;
    • Merli, Francesco;
    • Stelitano, Caterina;
    • Carella, Angelo Michele;
    • Fragasso, Alberto;
    • Montechiarello, Elisa;
    • Ricciuti, Giuseppina;
    • Pulsoni, Alessandro;
    • Paulli, Marco;
    • Franco, Vito;
    • Federico, Massimo
    Publication type:
    Article